Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Starpharma.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Is this the big news from Germany Pharmaxis was waiting for?
Health & Biotech
Health: Starpharma cancer drug passes first test, readies for next step
Health & Biotech
Health: China loves Aussie food, maybe next it’ll love MVP’s Green Whistle too
News
Short and Caught: The ASX stocks investors are shorting right now
Health & Biotech
Health: Ecofibre’s CBD hemp extract could help alleviate the opioid crisis
Health & Biotech
Health: EMVision has built its portable brain scanner, trial to begin imminently
Health & Biotech
Health: Bionomics heading towards redo of failed PTSD trial, shares fly 81pc
Health & Biotech
Health: Shredded Viva Leisure hits the gym and beats prospectus forecasts
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Health: Immuron takes a dive after drug fails in alcoholic hepatitis trial
Health & Biotech
Biotech entrepreneur Paul Hopper tells us why he joined ‘treasure chest’ Suda
Health & Biotech
Health: Paradigm in ‘no rush’ to partner with big pharma but analysts are alarmed
News
Lunchtime ASX small cap wrap: who’s nursing a new years hangover
Health & Biotech
Starpharma scores with condom in Japan
News
Lunchtime ASX small cap wrap: who’s still got a job for Christmas
Health & Biotech
Starpharma puts sex back on the menu for one in three women with $142m deal
Health & Biotech
